Fact CheckerSign in

NCT07839897Completed

EFFICACY AND TOLERANCE OF AN EMOLLIENT CREAM IN SKIN OF COLOR

EVALUATION OF THE EFFICACY AND TOLERANCE OF A FACE AND BODY EMOLLIENT CREAM IN SUBJECTS (INFANTS, CHILDREN, ADULTS) WITH MILD TO MODERATE ATOPIC DERMATITIS UNDER DERMATOLOGICAL CONTROL

Source: ClinicalTrials.gov · Last updated 24 Sept 2026

Brief summary (registry, in English)

The aim of this study is to evaluate the efficacy and tolerance of a face and body emollient cream in individuals (infants, children, adults) with phototypes IV-VI presenting mild to moderate atopic dermatitis (study under dermatological control)

Status (registry)
Completed
Study type
Interventional
Enrollment
59 (actual)
First submitted
18 Sept 2026
Start date
7 May 2025
Primary completion date
21 Aug 2025
Lead sponsor
Pierre Fabre Dermo Cosmetique
NCT number
NCT07839897

What you commit to

  • Study type: Interventional
  • Participants enrolled: 59
  • From 7 May 2025 to the primary completion date, 21 Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

  • Male or female (no minimum required);
  • Age as presented below:
    • 18-45 years old (n=20)
    • 2-17 years old (n=15)
    • 28 days to 23 months (n=15)
  • Phototypes IV-VI according to the Fitzpatrick scale following the distribution bellow:
    • Phototype IV: at least 2 by each age group
    • Phototypes V and VI: at least 75% by each age group and at least 2 by phototype
  • Subjects presenting atopic dermatitis according to the definition of "the U.K Working Party's Diagnostic Criteria for Atopic Dermatitis";
  • Presenting atopic dermatitis with a SCORAD from 15 to 30
  • Subjects (18-45 years old) presenting at least one PIH and/or post inflammatory hypopigmentation induced by atopic dermatitis
  • Subjects who used the same cleansing product on face and body, the same make-up (if applicable), the same sunscreen product for at least two weeks before inclusion and remain stable during the whole study

Age in the registry: 2 months to 45 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Bárbara NAHUM
Coordinator of this site? Confirm its status
Rio de JaneiroBrazilUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.